Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Mr. Filip JankuChief Medical Officer | -5,41k | 59,96k | Derivative Exercise and Sale | 13,41 - 24,50 | 2,61k | - |
| 2026-06-29 | Mr. Filip JankuChief Medical Officer | -6,00k | 92,34k | Derivative Exercise and Sale | 7,56 - 22,95 | 1,99k | - |
| 2026-06-29 | Dr. Anthony M. ManningIndependent Director | -10,00k | 189,50k | Derivative Exercise and Sale | 4,16 - 23,11 | 0,00 | - |
| 2026-06-23 | Mr. Filip JankuChief Medical Officer | -5,85k | 118,19k | Automatic Disposition | 20,22 | 1,99k | -74,58% |
| 2026-06-23 | Mr. Filip JankuChief Medical Officer | -36,00k | 491,85k | Derivative Exercise and Sale | 7,56 - 21,42 | 1,99k | - |
| 2026-06-23 | Ms. Jennifer ChampouxCOO | -2,18k | 34,84k | Derivative Exercise and Sale | 3,98 - 20,00 | 4,87k | - |
| 2026-06-23 | Dr. Sharon TownsonChief Scientific Officer | -3,00k | 41,58k | Derivative Exercise and Sale | 6,14 - 20,00 | 5,85k | - |
| 2026-06-17 | Dr. Sharon TownsonChief Scientific Officer | -3,00k | 38,58k | Derivative Exercise and Sale | 6,14 - 19,00 | 5,85k | - |
| 2026-06-17 | Ms. Jennifer ChampouxCOO | -2,18k | 32,68k | Derivative Exercise and Sale | 3,98 - 19,00 | 4,87k | - |
| 2026-06-01 | Dr. Markus WarmuthPresident, CEO & Director | -5,47k | 106,25k | Automatic Disposition | 19,41 - 19,73 | 408,54k | -1,32% |
| 2026-05-29 | Dr. Sharon TownsonChief Scientific Officer | -6,00k | 82,38k | Derivative Exercise and Sale | 6,14 - 19,87 | 5,85k | - |
| 2026-05-27 | Ms. Jennifer ChampouxCOO | -2,18k | 34,84k | Derivative Exercise and Sale | 3,98 - 20,00 | 4,87k | - |
| 2026-05-22 | Ms. Jennifer ChampouxCOO | -2,18k | 32,68k | Derivative Exercise and Sale | 3,98 - 19,00 | 4,87k | - |
| 2026-05-21 | Dr. Anthony M. ManningIndependent Director | -10,00k | 138,50k | Derivative Exercise and Sale | 4,16 - 18,01 | 0,00 | - |
| 2026-05-01 | Dr. Markus WarmuthPresident, CEO & Director | -5,47k | 103,45k | Automatic Disposition | 18,92 | 414,00k | -1,30% |
| 2026-04-14 | Dr. Markus WarmuthPresident, CEO & Director | -8,00k | 141,12k | Verkauf | 17,64 | 419,47k | -1,87% |
| 2026-04-09 | Mr. Philip NicksonChief Business & Legal Officer | -5,85k | 103,41k | Verkauf | 17,69 | 0,00 | -100,00% |
| 2026-03-04 | Mr. Edmund DunnInsider | -139,00 | 2,50k | Verkauf | 17,96 | 22,55k | -0,61% |
| 2026-03-02 | Dr. Markus WarmuthPresident, CEO & Director | -5,47k | 97,97k | Automatic Disposition | 17,92 | 427,47k | -1,26% |
| 2026-02-27 | Mr. Edmund DunnInsider | -25,70k | 120,25k | Derivative Exercise and Sale | 13,41 - 18,10 | 22,69k | - |
| 2026-02-23 | Mr. Filip JankuChief Medical Officer | -9,19k | 179,16k | Verkauf | 19,50 | 7,84k | -53,97% |
| 2025-11-19 | Versant Venture Management, LLCUnternehmen | -597,93k | 13,75M | Verkauf | 14,25 - 23,33 | 3,25M | -15,54% |
| 2025-12-04 | Versant Venture Management, LLCUnternehmen | -1,06M | 0,00 | Verkauf | - | 3,25M | -24,60% |
| 2026-01-07 | Dr. Markus WarmuthPresident, CEO & Director | -5,47k | 128,37k | Automatic Disposition | 23,24 - 24,57 | 432,94k | -1,25% |
| 2026-01-05 | Mr. Philip NicksonChief Business & Legal Officer | -3,16k | 47,86k | Verkauf | 15,17 | 5,85k | -35,06% |
| 2026-01-05 | Mr. Edmund DunnInsider | -1,04k | 15,76k | Verkauf | 15,17 | 22,69k | -4,38% |
| 2026-01-05 | Ms. Jennifer ChampouxCOO | -2,63k | 39,88k | Verkauf | 15,17 | 4,87k | -35,05% |
| 2026-01-05 | Mr. Filip JankuChief Medical Officer | -3,16k | 47,86k | Verkauf | 15,17 | 17,03k | -15,63% |
| 2026-01-05 | Dr. Markus WarmuthPresident, CEO & Director | -10,14k | 153,75k | Verkauf | 15,17 | 438,40k | -2,26% |
| 2026-01-05 | Dr. Sharon TownsonChief Scientific Officer | -3,16k | 47,86k | Verkauf | 15,17 | 5,85k | -35,06% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
